
Acadia Healthcare (ACHC) recently exhibited unusually high implied volatility in its Dec 19, 2025 $90 Call option, signaling market expectations for a significant future price movement. This options market activity contrasts with the company's fundamental outlook, as ACHC holds a Zacks Rank #4 (Sell), and analysts have recently revised current quarter earnings estimates downward from $0.84 to $0.71 per share. The divergence between high implied volatility and negative analyst sentiment suggests a potential trading opportunity, possibly for strategies involving selling premium.
Activity in the options market for Acadia Healthcare (ACHC) signals elevated investor expectations for a significant price movement, as evidenced by the high implied volatility in the December 19, 2025 $90 Call option. This market-implied volatility contrasts sharply with the company's deteriorating fundamental outlook. ACHC currently holds a Zacks Rank #4 (Sell), reflecting significant near-term headwinds. This negative sentiment is substantiated by recent analyst actions over the past 60 days, where three analysts have revised earnings estimates downward for the current quarter, with no corresponding upward revisions. The net effect of these revisions is a material reduction in the consensus earnings per share estimate for the quarter, which has fallen from $0.84 to $0.71. The divergence between the options market's pricing of high volatility and the fundamental analysts' bearish consensus suggests a potential setup for volatility-selling strategies, which would profit if the underlying stock's movement is less extreme than what the options market currently implies.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
moderately negative
Sentiment Score
-0.40
Ticker Sentiment